HLA class II alleles and histological features in chronically infected HCV patients with persistently normal ALT levels

被引：0
|
作者：
Renou, C
Halfon, P
Pol, S
Jouve, E
Bronowiki, JP
Arpurt, JP
Rifflet, H
Cacoub, P
Picon, M
Causse, X
Dantin, S
Caillat, S
机构：
[1] Alphabio, Marseille, France
[2] Necker, Paris, France
[3] CPCET, Marseille, France
[4] CHU, Nancy, France
[5] ANGH, Marseille, France
[6] Pitie Salpetriere, Paris, France
[7] Neker, Marseille, France
来源：
GASTROENTEROLOGY | 2001年 / 120卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2818
引用
收藏
页码：A554 / A554
页数：1
相关论文
共 50 条
  • [1] HLA class II alleles and histological features in chronically infected HCV patients with consistently normal ALT levels
    Renou, C
    Halfon, P
    Pol, S
    Jouve, E
    Bronowiki, JP
    Arpurt, JP
    Rifflet, H
    Cacoub, P
    Picon, M
    Causse, X
    Canva, V
    Denis, J
    Tran, A
    Dantin, S
    Bourliere, M
    Ouzan, D
    Pariente, A
    Alric, L
    Cartier, V
    Reville, M
    Caillat, S
    JOURNAL OF HEPATOLOGY, 2001, 34 : 114 - 114
  • [2] Histological features and HLA class II alleles in HCV chronically infected patients with persistently normal alanine aminotransferase levels
    Renou, C
    Halfon, P
    Pol, S
    Cacoub, P
    Jouve, E
    Bronowicki, JP
    Arpurt, J
    Rifflet, H
    Picon, M
    Causse, X
    Canva, V
    Denis, J
    Tran, A
    Bourliere, M
    Dantin, S
    Caillat-Zucman, S
    JOURNAL OF HEPATOLOGY, 2002, 36 : 169 - 170
  • [3] Histological features and HLA class II alleles in HCV chronically infected patients with persistently normal alanine aminotransferase levels.
    Renou, C
    Halfon, P
    Pol, S
    Cacoub, P
    Jouve, E
    Bronowicki, JP
    Arpurt, JP
    Rifflet, H
    Picon, M
    Causse, X
    Dantin, S
    Caillat-Zucman, S
    HEPATOLOGY, 2001, 34 (04) : 482A - 482A
  • [4] Histological features and HLA class II alleles in hepatitis C virus chronically infected patients with persistently normal alanine aminotransferase levels
    Renou, C
    Halfon, P
    Pol, S
    Cacoub, P
    Jouve, E
    Bronowicki, JP
    Arpurt, JP
    Rifflet, H
    Picon, M
    Causse, X
    Canva, V
    Denis, J
    Tran, A
    Bourlière, M
    Ouzan, D
    Pariente, A
    Dantin, S
    Alric, L
    Cartier, V
    Reville, M
    Caillat-Zucman, S
    GUT, 2002, 51 (04) : 585 - 590
  • [5] Viral kinetics in chronically HCV infected patients with persistently normal or elevated ALT levels.
    Kronenberger, B
    Herrmann, E
    Zeuzem, S
    HEPATOLOGY, 2003, 38 (04) : 642A - 642A
  • [6] Different HLA class II alleles prevent or favor the development of cirrhosis in HCV chronically-infected patients.
    Renou, C
    Hue, S
    Cacoub, P
    Halfon, P
    Thibaut, V
    Charlotte, F
    Piette, JC
    Picon, M
    Rifflet, H
    Pol, S
    Caillat-Zucman, S
    HEPATOLOGY, 2000, 32 (04) : 266A - 266A
  • [7] Reduced hepatocellular turnover in patients chronically infected with hepatitis C virus and persistently normal ALT levels
    Kronenberger, B
    Lee, JH
    Ruster, B
    Friedl, R
    Sarrazin, C
    Roth, WK
    Herrmann, G
    Zeuzem, S
    HEPATOLOGY, 1999, 30 (04) : 459A - 459A
  • [8] Virological and histological effects of interferon treatment in HCV positive patients with persistently normal ALT levels.
    Longo, F
    Tran, A
    Dantin, S
    Laffont, C
    Saint-Paul, MC
    Benzaken, S
    Rampal, P
    HEPATOLOGY, 1998, 28 (04) : 705A - 705A
  • [9] Association of extrahepatic manifestations with HLA class II alleles and with virus genotype in HCV infected patients
    Sebastiani, GD
    Bellisai, F
    Caudai, C
    Rottoli, P
    Valensin, PE
    Pippi, L
    Morozzi, G
    Porciello, G
    Donvito, A
    Bilenchi, R
    Giannini, F
    Galeazzi, M
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2005, 19 (1-2): : 17 - 22
  • [10] Antiviral treatment of HCV carriers with persistently normal ALT levels
    Puoti, Claudio
    Bellis, Lia
    Galossi, Alessandra
    Guarisco, Riccardo
    Nicodemo, Sabino
    Spilabotti, Lucia
    Unto, Orlando Dell'
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (02) : 150 - 152
12345